Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|January 1, 1992
Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC)V Ratanatharathorn, C Karanes, L G Lum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemiaR Dorr, C Karanes, C Spier, et al.
Bone Marrow Transplantation|June 1, 1994
Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimensK R Schultz, V Ratanatharathorn, E Abella, et al.
Bone Marrow Transplantation|December 1, 1993
Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipientsL G Lum, I D Joshi, S C Galoforo, et al.
Bone Marrow Transplantation|December 1, 1996
GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantationP Greenberg, R Advani, A Keating, et al.
Blood|December 1, 1991
Evidence for clonal disease by magnetic resonance imaging in patients with hypoplastic marrow disordersW Negendank, D Weissman, T M Bey, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Leukemia Research|September 4, 1999
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group StudyC Karanes, K J Kopecky, D R Head, et al.
American Journal of Clinical Oncology|November 5, 1997
Transplantation in patients with multiple myeloma: a multicenter comparative analysis of peripheral blood stem cell and allogeneic transplantM Varterasian, N Janakiraman, C Karanes, et al.
Bone Marrow Transplantation|February 16, 2000
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study GroupA F List, R Maziarz, P Stiff, et al.
Pageof 6